Cleocin T is a U.S. prescription brand for topical clindamycin phosphate used in acne treatment. Unlike Cleocin HCl capsules, the T line belongs on skin, not in the mouth. The label covers several 1% topical presentations, so a pharmacy search for the brand alone does not fully identify the item a clinician intended.
A named prescription may specify topical solution, gel, lotion or solution delivered with pledget applicators. Each has a different vehicle, container and handling context, even though the clindamycin concentration is expressed as 1%. Our topical clindamycin overview discusses route-wide choices; this page focuses on the identity of the Cleocin T branded family.
The practical goal is to recognize a legitimate branded product entry, distinguish it from a generic and confirm the exact route and package with a licensed U.S. pharmacy. No label, manufacturer listing or historical NDC by itself establishes real-time inventory, insurance coverage or medical suitability.
The current Cleocin T label identifies clindamycin phosphate topical solution, gel and lotion, and separately describes solution-soaked pledget applicators. Solution and lotion contain clindamycin equivalent to 10 mg/mL; gel contains the equivalent of 10 mg/g. Those units reflect different vehicles, not different routes of treatment.
Cleocin T is not the same brand as Cleocin vaginal cream or Cleocin HCl capsules. A partial listing that drops the letter T can blur this distinction; use the complete brand, formulation and package information rather than searching by the shared antibiotic name alone.
| Presentation | Strength wording | Container / distinguishing feature |
|---|---|---|
| Topical solution | 1%; equivalent to 10 mg/mL | Bottle; alcohol-containing topical vehicle |
| Topical solution pledgets | 1%; solution-soaked applicator | Individual pledgets in carton |
| Topical gel | 1%; equivalent to 10 mg/g | Gel tube; separate vehicle |
| Topical lotion | 1%; equivalent to 10 mg/mL | Squeeze bottle / emulsion |
| Oral or vaginal clindamycin | Not part of Cleocin T brand | Different route; not interchangeable |
The solution vehicle contains isopropyl alcohol and is labeled for external use. A solution bottle is not an oral liquid; its ingredients and handling instructions make it inappropriate for swallowing or intravaginal use. The label also identifies flammability precautions for the topical solution.
Pledgets contain a measured amount of the same topical solution in a separate applicator format. Someone prescribed a pledget carton should not assume that a bottled solution is an identical dispensing item. Explore the pledget formulation guide for the package distinction.
The Cleocin T gel is a semisolid topical preparation; the lotion is a liquid emulsion dispensed from a squeeze bottle. The label lists different excipients for each, which can matter when discussing tolerability, preferences and product selection with the prescriber.
Do not infer that all 1% clindamycin gels use the same application schedule. Clindagel, for example, has its own once-daily brand labeling. Follow the dispensed product directions rather than transferring instructions between unrelated brands.
A generic topical clindamycin may share an active ingredient and nominal strength with a Cleocin T product. That does not mean a pharmacist or patient should ignore its vehicle, dosage form, approved labeling or the actual prescription wording. Generic substitution rules also vary with the particular regulated product.
When the brand is not available, ask the pharmacist whether a suitable FDA-rated alternative can be dispensed under the prescription and state rules. The broader generic clindamycin guide explains why oral, skin and vaginal generic entries must never be combined into one interchangeable category.
Topical clindamycin is an antibiotic used in treatment plans for acne. It is not a one-product solution for every acne pattern, and antibiotic exposure should be considered in light of resistance prevention and the patient’s previous treatment history.
Modern acne guidance generally favors pairing topical antibiotics with benzoyl peroxide rather than antibiotic monotherapy. A clinician may choose separate products or a labeled fixed combination; see clindamycin for acne and the separate combination-product overview.
Read beyond an online search snippet. A complete entry should show the branded name, topical route, concentration, exact vehicle and package quantity. Cleocin T solution is commonly described in milliliter bottle sizes and pledget cartons, whereas gel uses gram or tube measures in the label.
Package codes can help a pharmacist identify a listing, but a recorded NDC is not evidence of in-stock supply. If an old photograph or shopping result conflicts with the pharmacist’s current ordering system, request confirmation of the exact labeled product before filling.
All Cleocin T presentations are prescription medicines. A U.S. pharmacy should validate a legitimate clinician order and match the intended product; sellers offering antibiotic-containing topical products without a prescription are not a safe workaround.
For a step-by-step identity check, see prescription requirements. For verifying the legitimacy of an online seller, the dedicated online pharmacy guide provides credential and pharmacist-access questions.
The amount paid can vary with the specific vehicle, package quantity, whether a brand or generic is dispensed, insurance restrictions and the pharmacy’s current charges. A branded name in a benefit list does not necessarily mean that the same form and package is covered.
Ask for the current patient-specific total rather than relying on undated online price snapshots. Our topical clindamycin cost guide focuses on price drivers without inventing offers or pharmacy rankings.
Cleocin T solution, gel and lotion are contraindicated in patients with hypersensitivity to clindamycin- or lincomycin-containing preparations, or a history of regional enteritis, ulcerative colitis or antibiotic-associated colitis. These are formal label contraindications, not merely general risk factors to mention after starting therapy. Although the product is applied to the skin, systemic absorption occurs and serious diarrhea or colitis has been reported with topical clindamycin.
The alcohol-containing solution is flammable, so keep it away from heat, sparks and flames. Avoid contact with eyes and mucous membranes, and use only the prescribed skin formulation. Significant or bloody diarrhea, severe abdominal cramping or a serious allergic reaction requires prompt assessment; consult the C. difficile risk guide for the distinction between common skin irritation and potentially serious antibiotic-associated illness.
Cleocin T is a single-antibiotic brand. Clindacin-P is a distinct pledget brand, Clindagel is a distinct gel product, and fixed-combination products such as Onexton contain other active ingredients. Brand similarity or a shared clindamycin ingredient cannot establish equivalent products.
Use Clindacin-P when the prescription identifies that pledget product; use the product-specific pages for each other brand. This approach avoids turning the Cleocin T page into a substitute for the entire topical product catalog.
Bring the exact name on the prescription, including the final T, and ask whether the intended vehicle is lotion, gel, solution or pledgets. Verify the concentration, package and any prescribed brand-only restriction. Ask whether another item would require prescriber authorization.
Before paying, confirm that the dispensing label matches the patient and instructions, the package is intact and the pharmacist can answer product questions. If the listed Cleocin T product cannot be obtained, follow the clinician–pharmacist substitution process rather than changing formulations independently.
A recommendation for oral clindamycin is not a different delivery method of Cleocin T. The oral product family addresses systemic antibiotics; the vaginal family addresses labeled bacterial-vaginosis products. Each route has separate indications and cautions.
This page is intentionally limited to the Cleocin T brand. It helps match a real topical prescription without giving disease-specific treatment plans, creating stock claims or duplicating every child dosage-form page.
No. Cleocin T topical clindamycin is prescription-only in the United States.
Yes. The U.S. Cleocin T label includes a topical gel as well as solution and lotion presentations.
They are topical applicators containing Cleocin T solution, supplied in a distinct package format.
No. Cleocin T is topical; Cleocin HCl is an oral capsule brand.
Not automatically. Their vehicles and package identities differ, so follow the prescription and pharmacist guidance.
No. Clindagel is a different branded 1% topical gel with its own labeling.
No. An NDC or drug label does not confirm real-time pharmacy inventory.
Its acne labeling does not make it appropriate for every skin condition. A clinician must determine the indication.
Cleocin T is contraindicated in people with clindamycin or lincomycin hypersensitivity, regional enteritis, ulcerative colitis or a history of antibiotic-associated colitis. A clinician should review the full label and patient history.